How Many People Died of Measles: Key Facts Up Front
Measles killed an estimated 136,000 people globally in 2022, according to WHO and CDC-backed estimates used in major disease burden studies. Most were children under five, and the vast majority had not received measles vaccine. That year, roughly 1 in 5 deaths occurred in children too young to have completed two recommended doses. In high-income countries, case fatality is typically below 1 in 1,000; in resource-limited settings with weak healthcare systems, it can be significantly higher due to malnutrition, delayed care, and complications like pneumonia or encephalitis. Below is a concise, verified breakdown of deaths by period and context, followed by factors that shape severity.
Notable Period Snapshot (approximate)
| Period | Reported/Estimated Annual Deaths | Source Type |
|---|---|---|
| 2000 (pre-vaccine scale-up) | ~545,000–778,000 | Modeled estimates (WHO/UN IGME) |
| 2010 | ~139,000–158,000 | Modeled estimates (WHO/UN IGME) |
| 2020 | ~90,000–122,000 | Modeled estimates (WHO/UN IGME) |
| 2022 | ~136,000 | Modeled estimates (WHO/UN IGME) |
| 2023 | Data pending; early indicators suggest increases in some regions due to disruptions | WHO/CDC situational reports |
These figures are model-based and vary by data quality, classification, and calendar-year reporting lags. They reflect deaths attributable to measles infection itself, not indirect effects of outbreaks on other conditions.
Measles Mortality Over Time: Long-Term Trends
Before widespread vaccination, measles was a leading cause of childhood death globally, with epidemics every 2–3 years causing severe seasonal spikes. Introduction of vaccine in the 1960s reduced deaths in high-income countries within a decade; global reductions accelerated after 2000 through Gavi-supported campaigns. Estimated annual deaths fell from several hundred thousand at the turn of the century to below 100,000 by the mid-2010s, then fluctuated. Modeling by major health institutions attributes changes to vaccine coverage, population growth, and campaign intensity, with uncertainty bands reflecting surveillance gaps in many countries.
Who Is at Highest Risk of Dying From Measles
Risk of severe outcome and death is not uniform. Highest risk groups include:
- Children under five, especially infants too young to be vaccinated
- Adults over 30 in settings with limited prior exposure or boosters
- People with compromised immune systems (HIV, malnutrition, cancer treatment)
- People with vitamin A deficiency or underlying lung/heart conditions
- Pregnant people, who face higher risks of preterm birth and pregnancy complications
Complications that most often lead to death include pneumonia, severe diarrhea and dehydration, and encephalitis. In settings with poor nutrition or limited oxygen and antibiotics, these complications are more likely to be fatal.
Global Estimates, Data Sources, and Uncertainty
Leading estimates come from WHO and CDC collaborations, using modeling that combines case reports, vaccination coverage surveys, and demographic data. Key points include:
- Modelled to account for under-reporting, especially where health systems are weak
- Estimates are updated periodically; year-to-year changes can reflect methodology as well as actual trends
- Third-dose (MCV2) coverage and timeliness strongly influence future death trends
Attributable Mortality Metrics (indicative)
| Metric | Verified Detail | Source Type/Notes |
|---|---|---|
| 2022 estimated deaths | ~136,000 | WHO/UN IGME modeled estimates |
| 2020 estimated range | ~90,000–122,000 | WHO/UN IGME modeled estimates |
| 2010 estimated deaths | ~139,000–158,000 | WHO/UN IGME modeled estimates |
| 2000 estimated deaths | ~545,000–778,000 | WHO/UN IGME modeled estimates |
| Typical case fatality (high-income) | CDC/WHO surveillance data | |
| Typical case fatality (low-income) | Higher; varies by outbreak and care access | Outbreak investigations and modeling |
Vaccination Impact on Measles Deaths
Two doses of measles vaccine are about 97% effective at preventing measles; one dose is about 93% effective. High coverage reduces both cases and deaths, but gaps in coverage create clusters of susceptibility. When coverage falls below approximately 92–95%, outbreaks become more likely and deaths can rise, especially in communities with limited healthcare access. Maintaining high routine immunization and responding rapidly to outbreaks are the primary public levers for further reducing measles mortality.
Misinformation and Common Misunderstandings
Some online claims conflate all respiratory illness deaths with measles or cite outdated single-country numbers without context. Reliable estimates rely on modeling that isolates measles-attributable deaths and compares scenarios with and without vaccination. Because measles can predispose to fatal pneumonia and encephalitis years after initial infection, the full burden is sometimes underappreciated. Conversely, very high aggregate numbers sometimes misattribute indirect effects of disease outbreaks to measles alone.
What You Can Do to Reduce Risk
Ensure you and your household are up to date with measles-containing vaccines per national guidance; in most schedules this means two doses. Verify children’s immunization records before school entry and check your own history if unsure. If an outbreak is occurring nearby, follow local public health guidance on testing, isolation, and post-exposure prophylaxis. Vitamin A supplementation may reduce severity in children with deficiency, depending on local protocols. Seek care early for high fever, rash, cough, or breathing difficulties, and monitor for severe symptoms such as persistent confusion, severe dehydration, or difficulty breathing.